This compound is primarily used in the treatment of conditions related to elevated uric acid levels, such as gout and hyperuricemia. It works by inhibiting the URAT1 transporter in the kidneys, which plays a key role in the reabsorption of uric acid. By blocking this transporter, it promotes the excretion of uric acid through urine, thereby reducing its concentration in the bloodstream. This mechanism helps alleviate symptoms like joint pain and inflammation associated with gout. Additionally, it may be explored for potential applications in managing kidney stones caused by uric acid crystallization. Its targeted action makes it a valuable therapeutic option for patients who do not respond adequately to conventional treatments like allopurinol or febuxostat.